Idorsia Ltd. provided earnings guidance for the full year of 2022. The company expects US GAAP operating loss of around CHF 840 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.278 CHF | +1.61% | -12.18% | +7.76% |
06-03 | Idorsia Ltd. Announces New Data with Daridorexant to Be Presented at Sleep 2024 | CI |
05-21 | Idorsia Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.76% | 457M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- IDIA Stock
- News Idorsia Ltd
- Idorsia Ltd Provides Earnings Guidance for the Full Year of 2022